Stock Events

Stock Events

Search...

Ovid Therapeutics (OVID) Q2 2024 Earnings

14MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.22

-0.17

-0.11

-0.05

Details

Expected EPS

-0.223469

Actual EPS

-0.17

Surprise EPS

0.05

Surprise Percent

+23.93%

Description

Ovid Therapeutics (OVID) has reported earnings of -0.17 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.